Nordea Investment Management Ab Ligand Pharmaceuticals Inc Transaction History

Nordea Investment Management Ab

  • $85.8 Billion
  • Q3 2024

A detailed history of Nordea Investment Management Ab transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Nordea Investment Management Ab holds 55,602 shares of LGND stock, worth $6.07 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
55,602
Previous 58,699 5.28%
Holding current value
$6.07 Million
Previous $4.95 Million 12.62%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$82.7 - $110.11 $256,121 - $341,010
-3,097 Reduced 5.28%
55,602 $5.57 Million
Q2 2024

Aug 08, 2024
SELL
$68.53 - $87.91 $659,875 - $846,485
-9,629 Reduced 14.09%
58,699 $4.95 Million
Q1 2024

May 02, 2024
SELL
$68.64 - $89.2 $44,135 - $57,355
-643 Reduced 0.93%
68,328 $4.99 Million
Q4 2023

Jan 10, 2024
SELL
$49.57 - $72.63 $118,026 - $172,932
-2,381 Reduced 3.34%
68,971 $4.93 Million
Q3 2023

Nov 13, 2023
SELL
$58.86 - $72.67 $46,852 - $57,845
-796 Reduced 1.1%
71,352 $4.28 Million
Q2 2023

Jul 07, 2023
BUY
$69.53 - $79.33 $35,112 - $40,061
505 Added 0.7%
72,148 $5.2 Million
Q1 2023

Apr 19, 2023
SELL
$65.67 - $77.08 $146,444 - $171,888
-2,230 Reduced 3.02%
71,643 $5.27 Million
Q4 2022

Feb 08, 2023
BUY
$61.72 - $96.74 $242,744 - $380,478
3,933 Added 5.62%
73,873 $4.93 Million
Q3 2022

Oct 19, 2022
SELL
$0.01 - $107.56 $2 - $25,276
-235 Reduced 0.33%
69,940 $6.1 Million
Q2 2022

Aug 09, 2022
SELL
$74.52 - $117.06 $161,559 - $253,786
-2,168 Reduced 3.0%
70,175 $6.09 Million
Q1 2022

Apr 11, 2022
BUY
$94.99 - $151.56 $86,155 - $137,464
907 Added 1.27%
72,343 $8.46 Million
Q4 2021

Jan 20, 2022
SELL
$127.69 - $165.85 $67,803 - $88,066
-531 Reduced 0.74%
71,436 $11.2 Million
Q3 2021

Nov 01, 2021
SELL
$102.33 - $144.73 $7.36 Million - $10.4 Million
-71,967 Reduced 50.0%
71,967 $10.1 Million
Q3 2021

Nov 01, 2021
BUY
$102.33 - $144.73 $7.25 Million - $10.3 Million
70,870 Added 97.0%
143,934 $20.1 Million
Q2 2021

Jul 16, 2021
BUY
$113.03 - $155.64 $921,872 - $1.27 Million
8,156 Added 12.57%
73,064 $9.59 Million
Q1 2021

May 17, 2021
SELL
$99.52 - $215.83 $126,489 - $274,319
-1,271 Reduced 1.92%
64,908 $9.96 Million
Q4 2020

Feb 12, 2021
BUY
$80.55 - $106.05 $1.98 Million - $2.61 Million
24,643 Added 59.33%
66,179 $6.58 Million
Q3 2020

Nov 09, 2020
SELL
$89.56 - $126.72 $3.67 Million - $5.19 Million
-40,994 Reduced 49.67%
41,536 $4.07 Million
Q2 2020

Aug 13, 2020
BUY
$68.28 - $123.65 $2.83 Million - $5.13 Million
41,449 Added 100.9%
82,530 $9.23 Million
Q1 2020

May 15, 2020
BUY
$63.37 - $107.88 $105,320 - $179,296
1,662 Added 4.22%
41,081 $3.03 Million
Q4 2019

Feb 11, 2020
BUY
$96.94 - $113.59 $100,526 - $117,792
1,037 Added 2.7%
39,419 $4.14 Million
Q3 2019

Nov 13, 2019
BUY
$86.25 - $120.16 $1.09 Million - $1.52 Million
12,645 Added 49.13%
38,382 $3.84 Million
Q2 2019

Aug 14, 2019
BUY
$107.38 - $129.34 $857,966 - $1.03 Million
7,990 Added 45.02%
25,737 $2.94 Million
Q1 2019

May 20, 2019
SELL
$105.93 - $142.47 $83,684 - $112,551
-790 Reduced 4.26%
17,747 $2.23 Million
Q4 2018

Feb 14, 2019
SELL
$128.36 - $272.13 $8,215 - $17,416
-64 Reduced 0.34%
18,537 $2.52 Million
Q3 2018

Nov 14, 2018
BUY
$211.18 - $274.49 $557,092 - $724,104
2,638 Added 16.53%
18,601 $5.11 Million
Q2 2018

Aug 13, 2018
SELL
$150.77 - $207.98 $604,135 - $833,375
-4,007 Reduced 20.07%
15,963 $3.31 Million
Q1 2018

May 14, 2018
BUY
$138.63 - $182.62 $238,304 - $313,923
1,719 Added 9.42%
19,970 $3.3 Million
Q4 2017

Feb 12, 2018
BUY
$128.36 - $147.04 $128,616 - $147,334
1,002 Added 5.81%
18,251 $2.5 Million
Q3 2017

Nov 09, 2017
BUY
$120.91 - $137.94 $2.09 Million - $2.38 Million
17,249
17,249 $2.35 Million

Others Institutions Holding LGND

# of Institutions
256
Shares Held
18.1M
Call Options Held
26.8K
Put Options Held
9.3K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.84B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email